Results 281 to 290 of about 77,953 (304)
Some of the next articles are maybe not open access.

Interferon-Gamma Release Assay Testing for Latent Tuberculosis Infection: A Health Technology Assessment.

Ontario health technology assessment series
Many people infected with the Mycobacterium tuberculosis complex (the bacteria that cause tuberculosis [TB]) have an inactive stage of infection known as latent tuberculosis infection (LTBI). A person with LTBI is at risk of developing active TB. Screening for, and treating people with, LTBI is an important part of preventing adverse health outcomes ...
openaire   +1 more source

Interferon gamma release assays: principles and practice

Enfermedades Infecciosas Y Microbiología Clínica, 2010
Ajit Lalvani, Manish Pareek
exaly  

Interferon-gamma Release Assays Should Not Replace Tuberculin Skin Tests in Screening Programs for Children

Pediatric Infectious Disease Journal, 2016
Marc, Tebruegge   +2 more
openaire   +2 more sources

[Interferon gamma release assay tests for the diagnosis of active tuberculosis].

Revue des maladies respiratoires, 2019
F-X, Blanc   +3 more
openaire   +1 more source

Interferon gamma for idiopathic pulmonary fibrosis

Lancet, The, 2009
Demosthenes Bouros
exaly  

Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls

Scandinavian Journal of Infectious Diseases, 2014
Daniel Faurholt-Jepsen   +2 more
exaly  

Interferon and Cancer Treatment

Ca-A Cancer Journal for Clinicians, 1978
exaly  

Home - About - Disclaimer - Privacy